Smith & Nephew plc vs iShares Broad USD Investment Grade Corporate Bond — how do they compare? Smith & Nephew plc trades at $30.05 (market cap $12.54B), while iShares Broad USD Investment Grade Corporate Bond trades at $50.21. The key difference: Smith & Nephew plc pays a 2.65% dividend while iShares Broad USD Investment Grade Corporate Bond pays none, and Smith & Nephew plc is trading nearer its 52-week high, iShares Broad USD Investment Grade Corporate Bond nearer its low. Which is the better fit depends on your goals.
| SNN | USIG | |
|---|---|---|
Market Cap | $12.54B | — |
Sector | Health | Fixed Income |
52-Week High | $38.70 | $52.69 |
52-Week Low | $28.73 | $50.18 |
Enterprise Value | $15.57B | — |
Dividend Yield | 2.65% | — |
Trailing returns across standard periods
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →USIG is a low-cost ETF providing broad exposure to over 11,000 U.S. investment-grade corporate bonds. It tracks the ICE BofA US Corporate Index, featuring high-quality debt from 2026 leaders like Citigroup, Bank of America, and Oracle.
Read more on USIG →